Zaryouh H, Vara-Messler M, Vignau J, Machiels J-P, Wouters A, Schmitz S, Corbet C. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resist Updates. 2022;60:100806.

Article  Google Scholar 

Rad HS, Shiravand Y, Radfar P, Ladwa R, Perry C, Han X, Warkiani ME, Adams MN, Hughes BG, O’Byrne K. Understanding the tumor microenvironment in head and neck squamous cell carcinoma. Clin Translational Immunol. 2022;11:e1397.

Article  CAS  Google Scholar 

Chow LQ. Head and neck cancer. N Engl J Med. 2020;382:60–72.

Article  CAS  PubMed  Google Scholar 

Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Reviews Disease Primers. 2020;6:92.

Article  PubMed  Google Scholar 

Gavrielatou N, Fortis E, Spathis A, Anastasiou M, Economopoulou P, Foukas G-RP, Lelegiannis IM, Rusakiewicz S, Vathiotis I, Aung TN. B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma. Ann Oncol 2023.

Seiwert TY, Burtness B, Mehra R, Weiss J, Berger R, Eder JP, Heath K, McClanahan T, Lunceford J, Gause C. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol. 2016;17:956–65.

Article  CAS  PubMed  Google Scholar 

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375:1856–67.

Article  PubMed  PubMed Central  Google Scholar 

Borel C, Jung AC, Burgy M. Immunotherapy breakthroughs in the treatment of recurrent or metastatic head and neck squamous cell carcinoma. Cancers. 2020;12:2691.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394:1915–28.

Article  CAS  PubMed  Google Scholar 

Fasano M, Della Corte CM, Di Liello R, Viscardi G, Sparano F, Iacovino ML, Paragliola F, Piccolo A, Napolitano S, Martini G. Immunotherapy for head and neck cancer: Present and future. Crit Rev Oncol/Hematol. 2022;174:103679.

Article  PubMed  Google Scholar 

Cohen EE, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le Q-T, Lee NY, Leidner R, Lewis RL. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer. 2019;7:1–31.

Article  PubMed  PubMed Central  Google Scholar 

Cohen EE, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn M-J, Soria A, Machiels J-P, Mach N, Mehra R. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet. 2019;393:156–67.

Article  CAS  PubMed  Google Scholar 

Mehra R, Seiwert TY, Gupta S, Weiss J, Gluck I, Eder JP, Burtness B, Tahara M, Keam B, Kang H. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012. Br J Cancer. 2018;119:153–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gavrielatou N, Doumas S, Economopoulou P, Foukas PG, Psyrri A. Biomarkers for immunotherapy response in head and neck cancer. Cancer Treat Rev. 2020;84:101977.

Article  CAS  PubMed  Google Scholar 

Sadeghirad H, Liu N, Monkman J, Ma N, Cheikh BB, Jhaveri N, Tan CW, Warkiani ME, Adams MN, Nguyen Q. Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. Front Immunol. 2023;14:1135489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sadeghirad H, Monkman J, Mehdi AM, Ladwa R, O’Byrne K, Hughes BG, Kulasinghe A. Dissecting tissue compartment-specific protein signatures in primary and metastatic oropharyngeal squamous cell carcinomas. Front Immunol. 2022;13:895513.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577:561–5.

Article  CAS  PubMed  Google Scholar 

Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruffin AT, Cillo AR, Tabib T, Liu A, Onkar S, Kunning SR, Lampenfeld C, Atiya HI, Abecassis I, Kürten CH. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat Commun. 2021;12:3349.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayashi Y, Makino T, Sato E, Ohshima K, Nogi Y, Kanemura T, Honma K, Yamashita K, Saito T, Tanaka K. Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors. Br J Cancer. 2023;128:2175–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sautès-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19:307–25.

Article  PubMed  Google Scholar 

Werner F, Wagner C, Simon M, Glatz K, Mertz KD, Läubli H, Griss J, Wagner SN. A standardized analysis of tertiary lymphoid structures in human melanoma: disease progression-and tumor site-associated changes with germinal center alteration. Front Immunol. 2021;12:675146.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauldin IS, Mahmutovic A, Young SJ, Slingluff CL. Multiplex immunofluorescence histology for immune cell infiltrates in melanoma-associated tertiary lymphoid structures. Melanoma: Methods Protocols 2021:573–87.

Schürch CM, Bhate SS, Barlow GL, Phillips DJ, Noti L, Zlobec I, Chu P, Black S, Demeter J, McIlwain DR. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell. 2020;182:1341–59. e1319.

Article  PubMed  PubMed Central  Google Scholar 

Sato Y, Silina K, van den Broek M, Hirahara K, Yanagita M. The roles of tertiary lymphoid structures in chronic diseases. Nat Rev Nephrol 2023:1–13.

Pfannstiel C, Strissel PL, Chiappinelli KB, Sikic D, Wach S, Wirtz RM, Wullweber A, Taubert H, Breyer J, Otto W. The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes. Cancer Immunol Res. 2019;7:923–38.

Article  CAS  PubMed  Google Scholar 

Monkman J, Moradi A, Yunis J, Ivison G, Mayer A, Ladwa R, O’Byrne K, Kulasinghe A. Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging. J Transl Med. 2024;22:239.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sadeghi Rad H, Bazaz SR, Monkman J, Ebrahimi Warkiani M, Rezaei N, O’Byrne K, Kulasinghe A. The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies. Clin Translational Immunol. 2020;9:e1215.

Article  Google Scholar 

Liu N, Bhuva DD, Mohamed A, Bokelund M, Kulasinghe A, Tan CW, Davis MJ. standR: spatial transcriptomic analysis for GeoMx DSP data. Nucleic Acids Res. 2024;52:e2–2.

Article  PubMed  Google Scholar 

Gagnon-Bartsch JA, Jacob L, Speed TP. Removing unwanted variation from high dimensional data with negative controls. Berkeley: Tech Rep Dep Stat Univ Calif 2013:1–112.

Jhaveri N, Ben Cheikh B, Nikulina N, Ma N, Klymyshyn D, DeRosa J, Mihani R, Pratapa A, Kassim Y, Bommakanti S. Mapping the spatial proteome of head and neck tumors: key immune mediators and metabolic determinants in the tumor microenvironment. GEN Biotechnol. 2023;2:418–34.

Article  CAS  Google Scholar 

Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:1–7.

Article